期刊文献+

诱导多功能干细胞治疗脊髓损伤的现状及思考 被引量:2

Thinking and actuality of induced pluripotent stem cells to treat spinal cord injury
下载PDF
导出
摘要 背景: 目前对脊髓损伤的治疗方法有激素冲击治疗,急诊手术减压及最新发展的干细胞治疗等方法。已有大量工作聚焦于干细胞治疗脊髓损伤的研究方面,并已成为热点。目的: 综述诱导多功能干细胞治疗脊髓损伤的相关研究现状及未来发展趋势。方法: 应用计算机检索PubMed数据库1980年1月至2012年12月期间的相关文章,检索关键词为"spine injury,induced pluripotent stem cells,IPS"。结果与结论: 共纳入35篇文章,均就诱导多能干细胞治疗脊髓损伤持赞同或支持态度。结果表明,诱导多功能干细胞直接来源于自体分离得到,解决了干细胞移植中伦理以及道德等问题,同时避免了异体排斥反应也为移植提供了大量的细胞来源。对于脊髓损伤的治疗方面目前只有动物实验及少量临床实验支持,但其在动物实验中效果良好,安全性较高。诱导多功能干细胞治疗脊髓损伤现存的问题主要是诱导多功能干细胞的诱导分化方法不成熟,并发症也较多。因此,诱导多功能干细胞的诱导分化及使用安全性将成为研究关键。 METHODS: A computer-based online search of PubMed (1980-01/2011-11) was performed for articles in English using the keywords of "spine injury, induced pluripotent stem cells, IPS" RESULTS AND CONCLUSION: A total of 35 articles were included in result analysis, in which, stem cell therapy for treatment of spinal cord injury is agreed or supported. Induced pluripotent stem cells are isolated directly from the body, which solves ethical and morel issues in the transplantation of stem cells, meanwhile avoids allograft rejection and also provides a large source of cells. Stem cell therapy for spinal cord injury is widely used in animal experiments but few in clinical application. However, stem cell therapy has a good effect in the animal experiments, and shows a higher safety. The existing problems of induced pluripotent stem cells to treat spinal cord injury mainly include immature differentiating method of induced pluripotent stem cells and more complications. Therefore, induced differentiation and security of induced pluripotent stem cells for treatment of spinal cord injury will become a research key.
出处 《中国组织工程研究》 CAS CSCD 2013年第27期5094-5100,共7页 Chinese Journal of Tissue Engineering Research
基金 国家自然科学基金项目(30973026) 安徽省自然科学基金项目(1104060625)~~
关键词 干细胞 干细胞学术探讨骨髓干细胞脊髓损伤诱导多功能干细胞并发症脊髓移植国家自然科学基金 stem cells stem cell academic discussion bone marrow-derived stem cells spinal cord injury induced pluripotent stem cells complications spinal cord transplantation National Natural Science Foundationof China
  • 相关文献

参考文献1

二级参考文献2

共引文献21

同被引文献32

  • 1肇旭.人类胚胎干细胞研究的伦理观分析[J].伦理学研究,2012(1):82-89. 被引量:6
  • 2王锐,高峰,何晓雄.纳米技术在生物医学工程中的应用[J].安徽建筑工业学院学报(自然科学版),2006,14(5):71-75. 被引量:2
  • 3崔婷婷,赵丽娟,刘岩,等.72例急性脊髓损伤应用单唾液酸神经节苷脂临床研究[J].中国医药指南,2010,5(8):294-296.
  • 4Qiaomu Tian,Huinan Liu;Electrophoretic deposition and characterizationof nanocomposites and nanoparticles on magnesiumsubstrates ,2015,4.
  • 5Tung HY, Su YC, Chen BM so on;Selective Delivery of PEGylatedCompounds to Tumor Cells by anti-PEG Hybrid Antibodies;MolCancer Ther. 2015 Apr 7. pii: molcanther.0151.2015. [Epubahead of print.
  • 6Martinelli V, Cellot G, Fabbro A, Bosi S so on;.Improvingcardiac myocytes performance by carbon nanotubes platformst;2013 Sep 3;4:239. doi: 10.3389/fphys.2013.00239.
  • 7Shixian Huang , Kun Shao , Yang Liu;Tumor-targeting andmicroenvironment-responsive smart nanoparticles for combinationtherapy of antiangiogenesis and apoptosis; ACS Nano.2013 Mar 26;7(3):2860-71. doi: 10.1021/nn400548g. Epub 2013Mar 12.
  • 8Tuszynski MH, Steeves JD, Fawcett JW, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics [J]. Spinal Cord, 2007, 45(3): 222-231.
  • 9Lammertse D, Tuszynski MH, Steeves JD, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design [J]. Spinal Cord, 2007, 45(3): 232-242.
  • 10Fawcett JW, Curt A, Steeves JD, et al. Guidelines for the con- duct of clinical trials for spinal cord injury as developed by the ICCP Panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials [J]. Spi- nal Cord, 2007, 45(3): 190-205.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部